Jafri Kuthubutheen1, Harvey Coates2, Corwyn Rowsell3, Julian Nedzelski4, Joseph M Chen4, Vincent Lin4. 1. Department of Otolaryngology - Head and Neck Surgery, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada; School of Surgery, University of Western Australia, Perth, Western Australia, Australia. Electronic address: jafri.kuth@gmail.com. 2. School of Surgery, University of Western Australia, Perth, Western Australia, Australia. 3. Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada. 4. Department of Otolaryngology - Head and Neck Surgery, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5, Canada.
Abstract
INTRODUCTION: Steroids have been shown to reduce the hearing threshold shifts associated with cochlear implantation. Previous studies have examined only the administration of steroids just prior to surgery. The aim of this study is to examine the role of extended preoperative systemic steroids in hearing preservation cochlear implantation. METHODS: An animal model of cochlear implantation was used. 24 Hartley strain guinea pigs with a mean weight of 768 g and normal hearing were randomised into a control group, a second group receiving a single dose of systemic dexamethasone one day prior to surgery, and a third group receiving a daily dose of systemic dexamethasone for 5 days prior to surgery. A specially designed cochlear implant electrode by Med-EL (Innsbruck) was inserted through a dorsolateral approach to an insertion depth of 5 mm and left in-situ. Auditory brain stem responses at 8 kHz, 16 kHz and 32 kHz were measured preoperatively, and 1 week, 1 month and 2 months postoperatively. Cochlear histopathology was examined at the conclusion of the study. RESULTS: At 1-week post operative, both groups receiving dexamethasone prior to implantation had smaller threshold shifts across all frequencies and which was significant at 32 kHz (p < 0.05). There were no differences among the three groups in the area of electrode related fibrosis. Spiral ganglion neuron (SGN) density was significantly higher in the group receiving steroids for 5 days, but only in the basal cochlear turn. DISCUSSION: This is study demonstrates the benefits of extended preoperative systemic steroids on hearing outcomes and SGN density in an animal model of cochlear implantation surgery.
INTRODUCTION:Steroids have been shown to reduce the hearing threshold shifts associated with cochlear implantation. Previous studies have examined only the administration of steroids just prior to surgery. The aim of this study is to examine the role of extended preoperative systemic steroids in hearing preservation cochlear implantation. METHODS: An animal model of cochlear implantation was used. 24 Hartley strain guinea pigs with a mean weight of 768 g and normal hearing were randomised into a control group, a second group receiving a single dose of systemic dexamethasone one day prior to surgery, and a third group receiving a daily dose of systemic dexamethasone for 5 days prior to surgery. A specially designed cochlear implant electrode by Med-EL (Innsbruck) was inserted through a dorsolateral approach to an insertion depth of 5 mm and left in-situ. Auditory brain stem responses at 8 kHz, 16 kHz and 32 kHz were measured preoperatively, and 1 week, 1 month and 2 months postoperatively. Cochlear histopathology was examined at the conclusion of the study. RESULTS: At 1-week post operative, both groups receiving dexamethasone prior to implantation had smaller threshold shifts across all frequencies and which was significant at 32 kHz (p < 0.05). There were no differences among the three groups in the area of electrode related fibrosis. Spiral ganglion neuron (SGN) density was significantly higher in the group receiving steroids for 5 days, but only in the basal cochlear turn. DISCUSSION: This is study demonstrates the benefits of extended preoperative systemic steroids on hearing outcomes and SGN density in an animal model of cochlear implantation surgery.
Authors: Alex D Sweeney; Jacob B Hunter; Matthew L Carlson; Alejandro Rivas; Marc L Bennett; Rene H Gifford; Jack H Noble; David S Haynes; Robert F Labadie; George B Wanna Journal: Otolaryngol Head Neck Surg Date: 2016-02-23 Impact factor: 3.497
Authors: Cristina Maria Blebea; Laszlo Peter Ujvary; Violeta Necula; Maximilian George Dindelegan; Maria Perde-Schrepler; Mirela Cristina Stamate; Marcel Cosgarea; Alma Aurelia Maniu Journal: Medicina (Kaunas) Date: 2022-05-31 Impact factor: 2.948
Authors: Magdalena Beata Skarzynska; Aleksandra Kolodziejak; Elżbieta Gos; Piotr Henryk Skarzynski; Artur Lorens; Adam Walkowiak Journal: Life (Basel) Date: 2022-03-27
Authors: Michel Kather; Sabine Koitzsch; Bernhard Breit; Stefan Plontke; Bernd Kammerer; Arne Liebau Journal: Metabolomics Date: 2021-05-24 Impact factor: 4.290
Authors: Ricardo Ferreira Bento; Fabiana Danieli; Ana Tereza de Matos Magalhães; Dan Gnansia; Michel Hoen Journal: Int Arch Otorhinolaryngol Date: 2016-02-16
Authors: Verena Scheper; Roland Hessler; Mareike Hütten; Maciej Wilk; Claude Jolly; Thomas Lenarz; Gerrit Paasche Journal: PLoS One Date: 2017-08-31 Impact factor: 3.240